REDW.ST
Price:
$1.185
Market Cap:
$3.15M
Redwood Pharma AB engages in the development of ophthalmic pharmaceutical therapies for unmet market needs. The company's lead development product is RP101, an eye drop that treats severe chronic dry eye disease in post-menopausal women. It uses IntelliGel, a supramolecular smart drug delivery system for development of topical formulation for ophthalmic uses, as well as for administration to the front of the eye. Redwood Pharma AB is based in Stockholm, Sweden.
Industry
Biotechnology
IPO Date
2016-06-15
Stock Exchange
STO
Ticker
REDW.ST
According to Redwood Pharma AB’s latest financial reports and current stock price. The company's current ROE is -98.20%. This represents a change of 219.62% compared to the average of -30.72% of the last 4 quarters.
The mean historical ROE of Redwood Pharma AB over the last ten years is -133.28%. The current -98.20% ROE has changed -26.32% with respect to the historical average. Over the past ten years (40 quarters), REDW.ST's ROE was at its highest in in the December 2015 quarter at 9.60%. The ROE was at its lowest in in the December 2017 quarter at -185.57%.
Average
-133.28%
Median
-106.33%
Minimum
-678.42%
Maximum
185.91%
Discovering the peaks and valleys of Redwood Pharma AB ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 180.64%
Maximum Annual ROE = 185.91%
Minimum Annual Increase = -140.12%
Minimum Annual ROE = -678.42%
| Year | ROE | Change |
|---|---|---|
| 2023 | -104.42% | 22.55% |
| 2022 | -85.20% | -35.02% |
| 2021 | -131.12% | -36.08% |
| 2020 | -205.15% | 55.76% |
| 2019 | -131.71% | 21.67% |
| 2018 | -108.25% | -84.04% |
| 2017 | -678.42% | 809.53% |
| 2016 | -74.59% | -140.12% |
| 2015 | 185.91% | 180.64% |
The current ROE of Redwood Pharma AB (REDW.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-106.91%
5-year avg
-131.52%
10-year avg
-133.28%
Redwood Pharma AB’s ROE is greater than Cline Scientific AB (publ) (-16.76%), greater than Duearity AB (publ) (-1424.53%), greater than Scandion Oncology A/S (-139.19%), greater than Asarina Pharma AB (publ) (-157.86%), greater than Bioservo Technologies AB (publ) (-100.76%), greater than Cyxone AB (publ) (-53.52%), greater than Ziccum AB (publ) (-253.28%), less than Bonzun AB (publ) (55.56%),
| Company | ROE | Market cap |
|---|---|---|
| -16.76% | $3.11M | |
| -1424.53% | $3.08M | |
| -139.19% | $962.52K | |
| -157.86% | $633.96K | |
| -100.76% | $1.41M | |
| -53.52% | $6.75M | |
| -253.28% | $8.56M | |
| 55.56% | $7.25M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Redwood Pharma AB using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Redwood Pharma AB or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Redwood Pharma AB's ROE?
How is the ROE calculated for Redwood Pharma AB (REDW.ST)?
What is the highest ROE for Redwood Pharma AB (REDW.ST)?
What is the 3-year average ROE for Redwood Pharma AB (REDW.ST)?
What is the 5-year average ROE for Redwood Pharma AB (REDW.ST)?
How does the current ROE for Redwood Pharma AB (REDW.ST) compare to its historical average?